Eyal Herzog
Cardiovascular Disease · New York, NYNPI 1205831401
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $512,675 of the $644,677 with a category attached, or 79.5%. Lantheus Medical Imaging, Inc. accounts for 97.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $151,805 and has fallen 64.7% since, to $53,575 in 2025. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,043 payments — averaging $618.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lantheus Medical Imaging, Inc.$631K
- Pfizer$12K
- C. R. Bard, Inc. & Subsidiaries$1K
- E.r. Squibb & Sons, L.L.C.$531
- AstraZeneca$76
- Nuwellis, Inc.$34
- plus $71 from 3 others
What the payments were for
- Consulting fees$1,6310%
- Speaking & faculty fees$512,67580%
- Travel & lodging$113,97318%
- Food & beverage$16,3973%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lantheus Medical Imaging, Inc. | 1,015 | $631,042 |
| Pfizer | 16 | $11,791 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $1,131 |
| E.r. Squibb & Sons, L.L.C. | 3 | $531 |
| AstraZeneca | 4 | $76 |
| Nuwellis, Inc. | 1 | $34 |
| Akcea Therapeutics, Inc. | 1 | $29 |
| Amgen | 1 | $22 |
| Cook Medical LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$644,677 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.
Other cardiovascular disease in New York
- Roger HajjarNew York$5.2M
- Gregg StoneNew York$2M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Megha PrasadNew York$813K
- Nisha JhalaniNew York$443K
- Roxana MehranNew York$432K
- Howard WeintraubNew York$328K
- Anuradha Lala-TrindadeNew York$324K
- Steven MarxNew York$323K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.